CKS2 and Its Role in Ferroptosis Resistance in Colon Cancer
Author Information
Author(s): Yang Leilei, Fang Chengfeng, Han Jiaju, Ren Yufeng, Yang Zaiping, Shen Lingyan, Luo Dinghai, Zhang Ruili, Chen Yan, Zhou Shenkang
Primary Institution: Taizhou Hospital, Wenzhou Medical University
Hypothesis
CKS2 modulates ferroptosis resistance in colon cancer through glutathione metabolism.
Conclusion
CKS2 suppresses ferroptosis in colon cancer by modulating glutathione metabolism, suggesting it as a potential therapeutic target.
Supporting Evidence
- CKS2 expression was elevated in colon cancer tissues.
- Knockdown of CKS2 enhanced ferroptosis in colon cancer cells.
- CKS2 overexpression reduced ferroptosis sensitivity.
- Inhibiting CKS2 promoted tumor ferroptosis by downregulating GPX4 expression.
- CKS2 knockdown increased sorafenib-induced ferroptosis in vitro and in vivo.
Takeaway
This study found that a protein called CKS2 helps colon cancer cells avoid a type of cell death called ferroptosis, which could be important for developing new treatments.
Methodology
The study used bioinformatics, RNA-seq, qRT-PCR, Western blot, and various assays to analyze the effects of CKS2 on colon cancer cells.
Limitations
The study did not explore the role of CKS2 in other forms of ferroptosis induced by different agents.
Participant Demographics
Patients with colon cancer who underwent surgical resection.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website